These results indicated that CCL5 was important in attracting CD8+ T lymphocytes towards HCC, suggesting that IGF1R, as an oncogene, could suppress CD8+ T cell recruitment to tumor environments by inhibiting CCL5 production. Here, CCL5 is linked to hepatocellular carcinoma.